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Sir,
Heat shock proteins (HSPs) are protein chaperones that
play important roles in maintaining protein homeostasis.
Ours and others’ research have shown that DNAJB2a
(encoded by DNAJB2) is capable of resolving aggregates
caused by TDP-43 (Chen et al., 2016), SOD1 (Novoselov
et al., 2013; Gess et al., 2014), huntingtin (Labbadia et al.,
2012) and mutant parkin (Rose et al., 2011). Given
DNAJB2’s neuronal enriched expression, it is not surprising
that it shows such effectiveness in resolving the protein
aggregates associated with neurodegenerative diseases.
The question is, is DNAJB2a the sole protein for that
role, and is DNAJB2a there to perform such function in
the case of neurodegeneration.
ALS is the neurodegenerative disease that most promin-
ently affects motor neurons. It is a heterogeneous disorder
where the majority of affected individuals have no family
history of ALS. Nevertheless, TDP-43 proteinopathy (i.e.
presence of insoluble, hyperphosphorylated, cytosolic
TDP-43 aggregates) is found as a common phenotype in
affected tissues in ALS with or without mutations in TDP-
43. This pathological feature is also seen in 60% of FTD
which supports the idea that FTD and ALS are on the same
disease spectrum. We agree with Frasquet et al.’s conclu-
sion that it would be interesting to study the genetic con-
tribution of DNAJB2a to ALS, but if we do ﬁnd any, we
predict they would be quite different than the ones found in
distal hereditary motor neuropathy (dHMN).
The known DNAJB2a mutations in association with
dHMN are c.352 + 1G4A (Blumen et al., 2012; Frasquet
et al., 2016) and c.229 + 1G4A (Gess et al., 2012), both of
which are autosomal recessive mutations altering the splicing
of DNAJB2 and lead to reduced protein expression.
However, in our unpublished study, we did not ﬁnd the
loss of DNAJB2 per se is sufﬁcient to trigger TDP-43 aggre-
gation. On the contrary, our data show that HSF1( + ) still
refolds TDP-43 when DNAJB2a is knocked down (unpub-
lished data). This result suggests that there are some func-
tional redundancy of HSP, and DNAJB2a, although is
capable in refolding TDP-43, is not the only HSP for this
task. Thereby, a simply loss of DNAJB2 is unlikely to cause
TDP-43 proteinopathy that is associated with ALS and FTD.
However, as we proposed in our original paper, it does
appear that the heat shock response as a whole is compro-
mised in ALS due to a yet to be determined cause. It will be
of great interest to investigate the genetic contribution from
not only DNAJB2a, but any HSPs and also HSF1.
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